BIO R&D Expense Growth
Bio-Rad Laboratories, Inc. Class A Common Stock · R&D Expense Growth

BIO R&D Expense Growth
Latest reported-13.18%period ending
BIO FY R&D Growth (YoY) (0.00% → -13.18%)
Latest values, visible window
High-resolution chart · PNG
BIO r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -13.1801% | |
| 19.5908% | |
| -3.6833% | |
| -1.4384% | |
| 19.6888% | |
| 7.4259% | |
| 1.7641% | |
| -20.4174% | |
| 21.5856% | |
| 6.6808% | |
| -12.418% | |
| 4.447% | |
| -1.4427% | |
| 14.8043% | |
| 8.2274% | |
| 5.3067% | |
| 2.5496% | |
| 13.5077% | |
| 13.9079% | |
| 7.1865% | |
| 6.2394% | |
| 14.9295% | |
| 13.6673% | |
| 8.3509% | |
| 12.332% | |
| 33.0859% | |
| 23.6715% | |
| -10.1952% | |
| 16.4141% | |
| 14.121% | |
| 14.9007% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |